Sparta Biomedical
PrivateLast Round
Convertible Debt
Sep 12, 2023
Total Funding Raised
$5M
Company Overview
Sparta Biomedical is a medical device company that develops chemically engineered cartilage-like implants to treat osteoarthritis and restore joint function.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sparta Biomedical Comparables
Compare Sparta Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hyalex | 91% | |
| Askel Healthcare | 87% | |
| Nanochon | 86% |
Sparta Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 12, 2023 | ||||
| Seed | Dec 14, 2021 |
Key People
Founding team and executive leadership
Sparta Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Duke Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 75% MoM.
- Oct 30, 2024
Monthly visitors increased 46% MoM, from 1.3K to 1.9K.
Sparta Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access